SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 210 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $44,000 | +2100.0% | 4,900 | +1675.4% | 0.00% | – |
Q4 2019 | $2,000 | -33.3% | 276 | -14.8% | 0.00% | – |
Q3 2019 | $3,000 | -25.0% | 324 | -10.7% | 0.00% | – |
Q2 2019 | $4,000 | -55.6% | 363 | -59.1% | 0.00% | – |
Q1 2019 | $9,000 | -98.8% | 888 | -97.9% | 0.00% | -100.0% |
Q3 2018 | $725,000 | +19.4% | 42,759 | 0.0% | 0.04% | +10.5% |
Q2 2018 | $607,000 | +15075.0% | 42,759 | +19514.2% | 0.04% | – |
Q1 2018 | $4,000 | -60.0% | 218 | -62.9% | 0.00% | -100.0% |
Q4 2017 | $10,000 | -50.0% | 588 | -56.4% | 0.00% | -50.0% |
Q3 2017 | $20,000 | +5.3% | 1,350 | -37.6% | 0.00% | 0.0% |
Q2 2017 | $19,000 | -5.0% | 2,163 | -38.5% | 0.00% | -33.3% |
Q3 2015 | $20,000 | -60.0% | 3,517 | -21.8% | 0.00% | -57.1% |
Q2 2015 | $50,000 | +13.6% | 4,500 | +60.7% | 0.01% | +16.7% |
Q1 2015 | $44,000 | -60.0% | 2,800 | -61.1% | 0.01% | -62.5% |
Q4 2014 | $110,000 | +189.5% | 7,200 | +166.7% | 0.02% | +166.7% |
Q4 2013 | $38,000 | +35.7% | 2,700 | 0.0% | 0.01% | +20.0% |
Q3 2013 | $28,000 | -47.2% | 2,700 | -60.2% | 0.01% | -54.5% |
Q2 2013 | $53,000 | – | 6,776 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |